GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (LTS:0I3Q) » Definitions » Cyclically Adjusted Book per Share

Corcept Therapeutics (LTS:0I3Q) Cyclically Adjusted Book per Share : $2.81 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Corcept Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Corcept Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was $5.267. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.81 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Corcept Therapeutics's average Cyclically Adjusted Book Growth Rate was 22.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 29.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 35.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Corcept Therapeutics was 43.80% per year. The lowest was -20.30% per year. And the median was 29.20% per year.

As of today (2024-05-24), Corcept Therapeutics's current stock price is $27.916. Corcept Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $2.81. Corcept Therapeutics's Cyclically Adjusted PB Ratio of today is 9.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Corcept Therapeutics was 61.22. The lowest was 2.39. And the median was 13.73.


Corcept Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Corcept Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Cyclically Adjusted Book per Share Chart

Corcept Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 1.25 1.69 2.12 2.65

Corcept Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.28 2.39 2.53 2.65 2.81

Competitive Comparison of Corcept Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Corcept Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corcept Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corcept Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Corcept Therapeutics's Cyclically Adjusted PB Ratio falls into.



Corcept Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Corcept Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.267/131.7762*131.7762
=5.267

Current CPI (Mar. 2024) = 131.7762.

Corcept Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.034 100.560 0.045
201409 -0.013 100.428 -0.017
201412 -0.033 99.070 -0.044
201503 0.098 99.621 0.130
201506 0.106 100.684 0.139
201509 0.124 100.392 0.163
201512 0.169 99.792 0.223
201603 0.184 100.470 0.241
201606 0.232 101.688 0.301
201609 0.282 101.861 0.365
201612 0.367 101.863 0.475
201703 0.438 102.862 0.561
201706 0.583 103.349 0.743
201709 0.756 104.136 0.957
201712 1.665 104.011 2.109
201803 1.868 105.290 2.338
201806 2.098 106.317 2.600
201809 2.248 106.507 2.781
201812 2.398 105.998 2.981
201903 2.486 107.251 3.054
201906 2.623 108.070 3.198
201909 2.930 108.329 3.564
201912 3.240 108.420 3.938
202003 3.573 108.902 4.324
202006 3.926 108.767 4.757
202009 4.215 109.815 5.058
202012 4.483 109.897 5.376
202103 4.385 111.754 5.171
202106 4.513 114.631 5.188
202109 4.685 115.734 5.334
202112 3.547 117.630 3.974
202203 3.839 121.301 4.171
202206 4.147 125.017 4.371
202209 4.397 125.227 4.627
202212 4.654 125.222 4.898
202303 4.896 127.348 5.066
202306 4.113 128.729 4.210
202309 4.482 129.860 4.548
202312 4.900 129.419 4.989
202403 5.267 131.776 5.267

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Corcept Therapeutics  (LTS:0I3Q) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Corcept Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=27.916/2.81
=9.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Corcept Therapeutics was 61.22. The lowest was 2.39. And the median was 13.73.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Corcept Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Corcept Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Corcept Therapeutics (LTS:0I3Q) Business Description

Industry
Traded in Other Exchanges
Address
149 Commonwealth Drive, Menlo Park, CA, USA, 94025
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Corcept Therapeutics (LTS:0I3Q) Headlines

No Headlines